Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
GNLK, bounced off a bottem. Good time to get in!
Do your dd. This is such an undervalued company
And let the run begin!
I dont get why people dont understand why this company is so undervalued prices like these could be flying off the market
Bid is heading up now. Ask is at .13! A bottom as been established I'm sure of it
GNLK,
Hitting new lows, This could easily surpass .50 mark in weeks.
DO your own DD
Very nice, I dont expect them to dilute either. this company will be worth something down the road
yeah that's what I was thinking for myself. I'm looking forward to their financial's aswell as an update from the company. I see good things coming.
If the department of defense used this to better the health of their soldiers oh man could you imagine the revenues that this company would be getting. Be soo crazy
In terms of companies on the OTC market, There aren't many which are actually going to progress onto further markets. I however believe that this one will continue onto further trading markets
yeah, I think in the long term this would defiently provide the best investment ever. In the short term/mid term this will rise once again. It's too undervalued
mm's trying to get in on this one, It wont happen!
GNLK Looks very interesting!
For those who just love financials, lets get this out of the way quickly so we can get into some more interesting topics. The company was Ranked Number 92 Fastest Growing Company in North Amerca on Deloitte's 2009 Technology Fast 500TM.
GeneLink experienced 1,991 percent growth during this period., 2004-2009.
"Being named to the Deloitte 500 is an outstanding achievement", said Monte Taylor, GeneLink CEO. "Substantially all of GeneLink`s revenue commenced with the launch of GeneWize Life Sciences, Inc. in the third quarter of 2008 and was based on roughly a half a year of revenue producing operations. Revenue for 2009 has already exceeded fiscal year 2008 and, assuming current trends at GeneWize continue, 2010 revenue should be even greater. As we continue to expand our science, product offerings, and the scope of our marketing efforts, we look forward to future growth."
Products Target Market: 1+ Trillion Dollars
Patents: 20+ Including On The DNA Collection System
Stage: High Growth, Young Company
Company Profile Date: Monday, February, 15, 2010
Today's company we are bringing to your attention is much more than the simplicity behind it being another stock market play. It is food for thought, a closer look at the future, and an investment in what could be the "Next Monster Company" as dubbed by the company's management and several other industry experts.
Following the Human Genome Project (HGP) and the successful mapping of the human DNA which was completed in 2003. Many new capabilities once thought out of our reach have become feasible, making the impossible, possible.
HGP's Impact On Medicine
All diseases have a genetic component, whether inherited or resulting from the body's response to environmental stresses like viruses or toxins. The successes of the HGP have even enabled researchers to pinpoint errors in genes--the smallest units of heredity--that cause or contribute to disease.
The ultimate goal is to use this information to develop new ways to treat, cure, or even prevent the thousands of diseases that afflict humankind. But the road from gene identification to effective treatments is long and fraught with challenges. In the meantime, biotechnology companies are racing ahead with commercialization by designing diagnostic tests to detect errant genes in people suspected of having particular diseases or of being at risk for developing them.Source: http://www.ornl.gov/sci/techresources/Human_Genome/medicine/medicine.shtml
Long before it was trendy for companies to begin talking about "personalized medicine", GeneLink (OTC: GNLK) was taking a leadership roll in the development of individualized therapies by focusing on four important genomic research areas:
Nutragenetics - The study of the relationship between our nutrient intake and gene function, with a particular emphasis of how this information could be applied to optimize an individual’s overall health regimen.
Dermagenetics - GeneLink’s pioneering research and development efforts literally launched the exciting new field of Dermagenetics® –the scientific application of genomic sciences to guide personalized, more effective skin care products and therapies.
Applied Technologies - GeneLink innovations led the company to develop a proprietary mass customization system for nutritional supplements and skin care product delivery. In 2005, GeneLink introduced DNA UltraCustom™ - the first scientifically proven anti-aging skin-care products for consumers based on their individual Skin-DNA profile.
Pharmacogenenomics – The study of the effects of individual genetic variations on drug response aimed at the development of therapies that maximize benefit or minimize side effects in individuals.
To support its vision, GeneLink has developed an impressive portfolio of DNA-based assessments and proprietary systems for individually tailored product manufacture and delivery. Each (patented or patent pending) GeneLink "panel" design is based on a carefully selected set of SNPs associated with a particular physiologic condition or imbalance such as cardiovascular health, oxidative stress, bone metabolism, etc. To enable this, Genelink has created the only patented, FDA reviewed, non-invasive, self-administered DNA collection system available today (US patent 6,291,171). The process starts when a person simply swabs the inside of their mouth (inner cheek) and mails the swabs back to GeneLink's laboratories. The DNA is analyzed for a SNP profile to determine:
VIDEO COVERAGE:
It has some very good fundamentals, I could hold this one for years with a good outlook.
Once this company begins posting less losses they will have a new turn of events for them. It's only a matter of time before they become fully profitable and distributing to mainstream health care.
Oh I'm sure they are just trying to stur panic. They just want cheap shares. They aren't getting mine I'll tell you that right now
Looks like a very interesting company. I see this going places.
lol funny thing is I just probably snagged one of those at that price. I got a few more thousand shares!
Just picked up about 8000 shares. Looking forward to some gains!
Not sure why people are selling this right now. Seems odd.
how fast do you think this will climb jps? I just got in the other day and bought some more today.
most likely that you subscribed or were involved with a thread. Basher shoo shoo
Again all that shows me is your someone is replying to your (most likely) bashing threads. If the stock is going down why do you care if others are here?
prove it then. Show us a screenshot of these alleged emails or get out of here. Until then hope you can get in at a good price. Good luck fella
It's all panic selling and consolidation. The stock jumped 50% in a day so it's still about 20% above where it was a few days ago. Nothing that much to worry over. I'm going long. All the short term players will wish they had stayed.
go fnxc
yeah lots of small orders going through. I'm thinking good high's later.
I dont get why people are selling this morning, atleast the weak hands are getting out. in at .0025 now!
you guys thinking that there is a press report coming out? that's what the hype is looking like right now.
weak hands to get rid of this morning, nothing to worry over in my opinion
yeah it's weird that it went through like that. Why someone would wanna sell that low is beyond me.
fnxc looking great in pre-market, it's at .0028 now!
probably a press report in my opinion. that and the stock has been oversold in recent months. It's a steal if you ask me.
it's looking very nice. What's this NITE you speak of?
RSI very nice level, Neither over bought or oversold. Looking nice. thinking a pop is gonna happen in the next hour
It's holding up very nicely in the afternoon. I'm excited for the gap up tomorrow. Porche here I come! :D
Glad I found this one as I was stumbling around the forums.
FNXC Great run today, expecting more as news comes out. Up almost 70% in the peak today.
FNXC has a run going on it right now. technicals showing that once .003 is broken it should fly.
How long do you think it would take to get to .1? I'm thinking once financials are released on this one it would have a good skyrocket bounce.